13854EGP
- Active ingredient
- basiliximab
- Strength
- 20 mg
- Form
- powder
- Manufacturer
- novartis
Uses
Used for prevention of acute organ rejection in kidney transplant recipients as part of immunosuppressive therapy.
Do not use if
Contraindicated in hypersensitivity to basiliximab or formulation components.
Side effects
May cause infections, gastrointestinal symptoms, hypertension, or edema.
Warnings
Increases susceptibility to infections due to immunosuppression.
How it works
A monoclonal antibody that blocks the interleukin-2 receptor on activated T lymphocytes.
Storage
Store refrigerated according to manufacturer instructions.
